Venlafaxine 37.5 mg Immediate Release Tablets — Generic For Effexor — Rising Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Venlafaxine tablets, USP are a prescription antidepressant used to treat major depressive disorder. The label says the medicine’s effectiveness was shown in controlled studies in adults with depression, and that long-term use should be re-evaluated periodically.

The label warns that antidepressants, including venlafaxine, can increase the risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies. Patients of all ages should be monitored for worsening depression, suicidal thoughts, unusual behavior changes, anxiety, agitation, irritability, insomnia, or other concerning symptoms, especially when treatment starts or doses change.

Venlafaxine should not be used with certain MAO inhibitors, and it can contribute to serotonin syndrome when combined with other serotonergic medicines. The label also warns about sustained increases in blood pressure, possible angle-closure glaucoma in people with narrow angles, and sexual side effects. Stopping the medicine suddenly can cause discontinuation symptoms, so the dose is generally reduced gradually when treatment is stopped.

Storage Information

protection, if needed, may be indicated if performed soon after ingestion or in symptomatic patients. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature] in a dry place. Dispense in a well-closed container as defined in the USP. store venlafaxine tablets ? Store venlafaxine tablets at room temperature between 20° to 25°C (68° to 77°F).

Key Counseling Points

• Take venlafaxine exactly as prescribed on the prescription label.
• Do not stop the medicine suddenly unless instructed, because abrupt discontinuation can cause symptoms.
• Watch for new or worsening depression, suicidal thoughts, unusual behavior changes, anxiety, agitation, irritability, insomnia, or restlessness.
• Tell a healthcare professional right away about symptoms that could suggest serotonin syndrome, such as agitation, hallucinations, fast heartbeat, blood pressure changes, fever, tremor, stiff muscles, or diarrhea.
• Tell your prescriber about all other medicines you take, especially MAO inhibitors and other serotonergic drugs.
• Report any problems with blood pressure, since venlafaxine can cause sustained increases in blood pressure.
• Tell your prescriber if you notice vision changes, since the label warns about angle-closure glaucoma in people with narrow angles.
• Tell your prescriber about sexual side effects, since decreased libido, erectile dysfunction, delayed ejaculation, or delayed/absent orgasm may occur.
• Do not use venlafaxine with MAOIs intended to treat psychiatric disorders or within the labelu2019s stated washout periods.
• If treatment is being stopped, the label recommends gradual dose reduction rather than abrupt cessation whenever possible.

Helpful Patient Education

Venlafaxine tablets, USP are a prescription antidepressant used for the treatment of major depressive disorder. DailyMed labeling describes clinical studies supporting its use in adults and notes that long-term treatment should be reviewed periodically to assess ongoing usefulness.

This medication has important safety warnings, including the need to monitor for worsening depression, suicidal thoughts or behavior, serotonin syndrome, blood pressure increases, and symptoms that may occur when treatment is stopped too quickly. It also should not be used with certain MAO inhibitors, and patients should follow the prescribing information closely.

Medication Summary last generated: 2026-07-12 03:09:34